NCT06164379View on ClinicalTrials.gov

Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 16, 2023

Primary Completion Date

December 16, 2024

Study Completion Date

December 16, 2024

Conditions
Primary Aldosteronism
Interventions
DRUG

Finerenone

At every visit, the clinic and ambulatory blood pressure will be measured. The levels of serum potassium, creatinine, renin, aldosterone will be examined. The urinary microalbumin creatinine ratio will be also examined.

DRUG

Spironolactone

At every visit, the clinic and ambulatory blood pressure will be measured. The levels of serum potassium, creatinine, renin, aldosterone will be examined. The urinary microalbumin creatinine ratio will be also examined.

Trial Locations (1)

200025

Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER